Literature DB >> 23376450

Retraction of: Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study [Eur Heart J (2009) 30:2461-2469, doi: 10.1093/eurheartj/ehp363].

.   

Abstract

Entities:  

Year:  2013        PMID： 23376450     DOI： 10.1093/eurheartj/eht030

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

Review 1.  A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors:  Tetsuya Tanimoto
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

Review 2.  Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?

Authors:  Flávio Danni Fuchs; James J DiNicolantonio
Journal:  Open Heart       Date:  2015-04-10

3.  Changes in Drug Utilization After Publication of Clinical Trials and Drug-Related Scandals in Japan: An Interrupted Time Series Analysis, 2005-2017.

Authors:  Shingo Fukuma; Tatsuyoshi Ikenoue; Yukari Yamada; Yoshiyuki Saito; Joseph Green; Takeo Nakayama; Shunichi Fukuhara
Journal:  J Epidemiol       Date:  2020-10-30       Impact factor: 3.211

4.  Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.

Authors:  Iekuni Ichikawa; Ellen Wright Clayton
Journal:  Account Res       Date:  2016       Impact factor: 2.622
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.